Claims for Patent: 7,291,591

Summary for Patent: 7,291,591

Title:	Alcohol-free transdermal insulin composition
Abstract:	The instant invention is directed toward a dermal delivery system composition comprising an aqueous base vehicle including Emu oil, at least one fatty acid alkyl ester, polyethylene glycol, and a gelling agent, in combination with a therapeutically effective amount of at least one species of insulin, and to processes for the manufacture and use thereof.
Inventor(s):	Fishman; Robert (Pembroke Plnes, FL)
Assignee:	All Natural FMG, Inc. (North Palm Beach, FL)
Application Number:	11/407,387
Patent Claims:	1. An alcohol-free composition effective for transdermal delivery of insulin comprising in combination: an effective amount of Emu Oil, an effective amount of at least one fatty acid alkyl ester, an effective amount of polyethylene glycol, a gelling agent in an amount effective for gelling, a therapeutically effective amount of insulin, and sterile water sufficient to make 100% W/W. 2. The composition for transdermal delivery of insulin as set forth in claim 1, wherein said fatty acid alkyl ester comprises at least one member selected from the group consisting of methyl laurate, methyl myristate, methyl palmitate, methyl stearate, methyl behenate, ethyl oleate, ethyl linoleate, butyl oleate, butyl stearate, isopropyl myristate, isopropyl palmitate, dodecyl acetate, tetradecyl octanote, cetyl palmitate, and stearyl stearate. 3. The composition for transdermal delivery of insulin as set forth claim 1, wherein said gelling agent comprises at least one member selected from the group consisting of guar gums, xanthan gums, carrageenan, cellulose, hydroxyalkyl celluloses, sodium carboxycelluloses, gelling agent including a combination of about 40% polyacrylamide, about 15% C.sub.13-C.sub.14 iso-paraffin, about 5% laureth-7 and water in an amount sufficient to make 100% W/W gelatin, agar, starch, or the like. 4. The composition for transdermal delivery of insulin as set forth in claim 1, wherein said polyethylene glycol is polyethylene glycol-8. 5. The composition for transdermal delivery of insulin as set forth in claim 1, further comprising an effective amount of methylsulfonylmethane. 6. An alcohol-free insulin composition effective for transdermal delivery formulated by a method comprising: providing a therapeutically effective amount of insulin; providing an effective amount of Emu oil in a high speed mixing apparatus; adding said insulin to said Emu oil and mixing until a homogeneously blended composition is formed; adding an effective amount of at least one fatty acid alkyl ester and an effective amount of polyethylene glycol to said homogeneous blend, and mixing for a sufficient amount of time; adding an effective amount of at least one gelling agent to achieve homogeneity and a gel-like consistency after blending; and adding additional gelling agent, if necessary, until desired gel consistency is achieved; adding sterile water sufficient to make 100% W/W and mixing to homogeneity: whereby said alcohol-free insulin composition effective for transdermal delivery is produced.

Details for Patent 7,291,591

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2023-04-11